John Kapoor, the former billionaire who founded drugmaker Insys Therapeutics, is among the executives to be sentenced for racketeering.Read More
The maker of a highly addictive fentanyl-based drug wants to sell its assets to pay some $250 million in debts. The move could let the company out of part of the settlement deal reached last week.Read More
The company agreed to make the payments to resolve federal criminal and civil investigations of its marketing practices. Five of its executives were convicted separately for the same practices.Read More
